| Jubeen Moaven, MD | |
|
3355 Riverbend Dr Ste 500, Springfield, OR 97477-8800 | |
| (541) 868-9500 | |
| (541) 685-5920 |
| Full Name | Jubeen Moaven |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 16 Years |
| Location | 3355 Riverbend Dr Ste 500, Springfield, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346401445 | NPI | - | NPPES |
| 500730957 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD180609 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
| Mercy Medical Center | Roseburg, OR | Hospital |
| Peace Harbor Medical Center | Florence, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eugene Gastroenterology Consultants Pc | 9830185875 | 14 |
News Archive
Pfizer Inc. announced today the publication of data showing that 57 percent of ALK-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib (PF-02341066), an investigational oral anaplastic lymphoma kinase (ALK) inhibitor, had either a complete (one patient) or partial (46 patients) response to treatment. Data from 82 patients in this Part 2 expansion cohort of the Phase 1 study were published in the October 28 issue of the New England Journal of Medicine.
Six researchers funded by the Office of Naval Research (ONR) were honored with Presidential Early Career Awards for Scientists and Engineers (PECASE), the nation's highest honor for young scientists and engineers, officials announced Aug.10.
Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world's deadliest diseases, which affects up to 2 billion people.
An international team of researchers received a five-year, $3.1 million grant from the National Institutes of Health to discover new and better ways to treat a pediatric congenital heart condition known as tetralogy of Fallot, which affects a total of 85,000 individuals in the United States.
California Gov. Jerry Brown defied the drug industry Monday by signing a sweeping drug price transparency bill that will force drugmakers to publicly justify big price hikes.
› Verified 6 days ago
| Entity Name | Eugene Gastroenterology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457374480 PECOS PAC ID: 9830185875 Enrollment ID: O20040423000749 |
News Archive
Pfizer Inc. announced today the publication of data showing that 57 percent of ALK-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib (PF-02341066), an investigational oral anaplastic lymphoma kinase (ALK) inhibitor, had either a complete (one patient) or partial (46 patients) response to treatment. Data from 82 patients in this Part 2 expansion cohort of the Phase 1 study were published in the October 28 issue of the New England Journal of Medicine.
Six researchers funded by the Office of Naval Research (ONR) were honored with Presidential Early Career Awards for Scientists and Engineers (PECASE), the nation's highest honor for young scientists and engineers, officials announced Aug.10.
Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world's deadliest diseases, which affects up to 2 billion people.
An international team of researchers received a five-year, $3.1 million grant from the National Institutes of Health to discover new and better ways to treat a pediatric congenital heart condition known as tetralogy of Fallot, which affects a total of 85,000 individuals in the United States.
California Gov. Jerry Brown defied the drug industry Monday by signing a sweeping drug price transparency bill that will force drugmakers to publicly justify big price hikes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jubeen Moaven, MD 3355 Riverbend Dr Ste 500, Springfield, OR 97477-8800 Ph: (541) 868-9500 | Jubeen Moaven, MD 3355 Riverbend Dr Ste 500, Springfield, OR 97477-8800 Ph: (541) 868-9500 |
News Archive
Pfizer Inc. announced today the publication of data showing that 57 percent of ALK-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib (PF-02341066), an investigational oral anaplastic lymphoma kinase (ALK) inhibitor, had either a complete (one patient) or partial (46 patients) response to treatment. Data from 82 patients in this Part 2 expansion cohort of the Phase 1 study were published in the October 28 issue of the New England Journal of Medicine.
Six researchers funded by the Office of Naval Research (ONR) were honored with Presidential Early Career Awards for Scientists and Engineers (PECASE), the nation's highest honor for young scientists and engineers, officials announced Aug.10.
Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world's deadliest diseases, which affects up to 2 billion people.
An international team of researchers received a five-year, $3.1 million grant from the National Institutes of Health to discover new and better ways to treat a pediatric congenital heart condition known as tetralogy of Fallot, which affects a total of 85,000 individuals in the United States.
California Gov. Jerry Brown defied the drug industry Monday by signing a sweeping drug price transparency bill that will force drugmakers to publicly justify big price hikes.
› Verified 6 days ago
Yiyakchu Jung Thapa, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Dr. Luis Eduardo Leyton-gonzalez, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Donald K Yang, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3355 Riverbend Dr, Suite 500, Springfield, OR 97477 Phone: 541-868-9500 Fax: 541-685-5920 | |
Dr. Peter A Kovach, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-683-5001 | |
Satyam Lakshmanbhai Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Priya Joseph Carden, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2073 Olympic Street, Springfield, OR 97477 Phone: 541-682-3550 Fax: 541-682-6703 | |
Jaswinder Kaur Singh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 |